Research
Myelin pathology is a key feature of X-linked dystonia-parkinsonism
Cell · By Priya Prakash, Kerry C. Limberg, Weimin Zhang, Yu Zhao, Klaudia F. Laborc, Anna O’Keeffe, Heather Appleby, Bryanna C. Vilnaigre, Michael R. O’Dea, Cara Fernandez-Cerado, Gierold Paul A. Legarda, Michelle Sy, Edwin L. Muñoz, Mark Angelo C. Ang, Cid Czarina E. Diesta, Justin Han, Ean Norenberg, Ellen B. Penney, D. Cristopher Bragg, Adam C. Mar, Ran Brosh, Jef D. Boeke & Shane A. Liddelow ·
The Brief
- A humanized mouse model of X-linked dystonia-parkinsonism shows widespread loss of myelin-forming oligodendrocytes.
- The same myelin pathology is also seen in the brains of patients with the disorder.
- The findings point to myelin loss as a possible contributor to this movement disorder.
Why it matters
It identifies a possible cellular mechanism behind a movement disorder, which could guide future research into causes and treatment targets.
Who’s affected
- researchers and clinicians studying dystonia and parkinsonism
- neuroscientists working on myelin and oligodendrocytes
- #neuroscience
- #movement disorders
- #myelin
- #oligodendrocytes
- #dystonia
- #parkinsonism
A humanized mouse model of X-linked dystonia-parkinsonism reveals widespread loss of myelin-forming oligodendrocytes, a pathology also seen in patient brains that points to a contributor to this movement disorder.